These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 30362835

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Breathing new life into West Nile virus therapeutics; discovery and study of zafirlukast as an NS2B-NS3 protease inhibitor.
    Martinez AA, Espinosa BA, Adamek RN, Thomas BA, Chau J, Gonzalez E, Keppetipola N, Salzameda NT.
    Eur J Med Chem; 2018 Sep 05; 157():1202-1213. PubMed ID: 30193218
    [Abstract] [Full Text] [Related]

  • 4. Miniature bovine pancreatic trypsin inhibitors (m-BPTIs) of the West Nile virus NS2B-NS3 protease.
    Ang MJ, Lim HA, Poulsen A, Wee JL, Ng FM, Joy J, Hill J, Chia CS.
    J Enzyme Inhib Med Chem; 2016 Sep 05; 31(sup2):194-200. PubMed ID: 27241372
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. SAR evolution towards potent C-terminal carboxamide peptide inhibitors of Zika virus NS2B-NS3 protease.
    Colarusso S, Ferrigno F, Ponzi S, Pavone F, Conte I, Abate L, Beghetto E, Missineo A, Amaudrut J, Bresciani A, Paonessa G, Tomei L, Montalbetti C, Bianchi E, Toniatti C, Ontoria JM.
    Bioorg Med Chem; 2022 Mar 01; 57():116631. PubMed ID: 35123179
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and in vitro evaluation of West Nile virus protease inhibitors based on the 2-{6-[2-(5-phenyl-4H-{1,2,4]triazol-3-ylsulfanyl)acetylamino]benzothiazol-2-ylsulfanyl}acetamide scaffold.
    Samanta S, Lim TL, Lam Y.
    ChemMedChem; 2013 Jun 01; 8(6):994-1001. PubMed ID: 23619931
    [Abstract] [Full Text] [Related]

  • 8. West Nile Virus NS2B/NS3 protease as an antiviral target.
    Chappell KJ, Stoermer MJ, Fairlie DP, Young PR.
    Curr Med Chem; 2008 Jun 01; 15(27):2771-84. PubMed ID: 18991636
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synthesis and in vitro evaluation of West Nile virus protease inhibitors based on the 1,3,4,5-tetrasubstituted 1H-pyrrol-2(5H)-one scaffold.
    Gao Y, Samanta S, Cui T, Lam Y.
    ChemMedChem; 2013 Sep 01; 8(9):1554-60. PubMed ID: 23868614
    [Abstract] [Full Text] [Related]

  • 12. Small molecule pan-dengue and West Nile virus NS3 protease inhibitors.
    Cregar-Hernandez L, Jiao GS, Johnson AT, Lehrer AT, Wong TA, Margosiak SA.
    Antivir Chem Chemother; 2011 May 12; 21(5):209-17. PubMed ID: 21566267
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Characterization of the West Nile virus protease substrate specificity and inhibitors.
    Mueller NH, Yon C, Ganesh VK, Padmanabhan R.
    Int J Biochem Cell Biol; 2007 May 12; 39(3):606-14. PubMed ID: 17188926
    [Abstract] [Full Text] [Related]

  • 15. Homology modeling and molecular dynamics simulations of Dengue virus NS2B/NS3 protease: insight into molecular interaction.
    Wichapong K, Pianwanit S, Sippl W, Kokpol S.
    J Mol Recognit; 2010 May 12; 23(3):283-300. PubMed ID: 19693793
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Homology modeling and molecular dynamics study of West Nile virus NS3 protease: a molecular basis for the catalytic activity increased by the NS2B cofactor.
    Zhou H, Singh NJ, Kim KS.
    Proteins; 2006 Nov 15; 65(3):692-701. PubMed ID: 16972281
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.